Human Protein Blocks Cell Defense, Aiding Herpes Virus Replication

Greg Howard
9th April, 2025

Human Protein Blocks Cell Defense, Aiding Herpes Virus Replication

In support of its proviral role, ADAR1 suppresses the activation of the antiviral protein PKR, which is triggered during Herpes simplex virus 1 (HSV-1) infection by early viral gene expression (a) and the direct binding of PKR to viral transcripts (e).

Image adapted from: Parchure et al. / CC BY (Source)

Key Findings

  • Researchers at the University of Wisconsin-Madison found that the enzyme ADAR1 helps herpes simplex virus replicate by controlling the body’s defense system
  • When ADAR1 is absent, a defense protein called PKR becomes overactive, stopping protein production and reducing the virus's ability to multiply
  • Targeting ADAR1 could offer new ways to prevent the virus from spreading effectively
ADAR1, a key enzyme involved in RNA editing, plays a crucial role in regulating the immune response during viral infections. In a recent study conducted by researchers at the University of Wisconsin-Madison[1], the function of ADAR1 in the replication of herpes simplex virus 1 (HSV-1) was explored, revealing its significant impact on the virus's ability to replicate within host cells. ADAR1 catalyzes the conversion of adenosine to inosine in double-stranded RNA (dsRNA), a process known as A-to-I RNA editing. This editing alters the genetic information within RNA molecules, contributing to the diversity of the transcriptome. Previous research has shown that ADAR1 helps prevent the overactivation of innate immune sensors like MDA5, PKR, and ZBP1, which detect viral RNA and trigger immune responses[2]. However, the specific role of ADAR1 in the context of herpesvirus replication was not well understood. The study found that in the absence of ADAR1, HSV-1 infection leads to the hyperactivation of PKR, a protein kinase that plays a pivotal role in the antiviral response. This hyperactivation results in the phosphorylation of eIF2α, a factor essential for initiating protein synthesis. When eIF2α is phosphorylated, it causes a translational arrest, effectively halting protein production and thereby reducing viral replication. This indicates that ADAR1 normally acts to suppress PKR activity, allowing the virus to replicate more efficiently within the host cells. To further understand this mechanism, the researchers used various methods to manipulate PKR activity. They silenced PKR or inhibited its downstream effectors using viral proteins like ICP34.5 or pharmacological agents such as ISRIB. These interventions were able to rescue viral replication in cells deficient in ADAR1, underscoring the critical role of ADAR1 in modulating the immune response to HSV-1. Additionally, the study demonstrated that upon HSV-1 infection, the ADAR1 p150 isoform interacts directly with PKR, preventing its hyperactivation. This interaction is essential for maintaining the balance between effective viral replication and an appropriate immune response. By raising the activation threshold for PKR, ADAR1 ensures that the immune system does not overreact, which could otherwise be detrimental to both the host and the virus. These findings build upon earlier research that highlighted the complex regulation of RNA editing by ADAR enzymes across different tissues and species[2]. The extensive profiling of A-to-I RNA editing conducted in the prior study provided a foundation for understanding how ADAR1 functions in various biological contexts. The current study expands on this by specifically elucidating the role of ADAR1 in viral infections, particularly in the context of HSV-1. The research institutions involved, including the University of Rijeka in Croatia, Ghent University in Belgium, and the University of Padova in Italy, contributed to this comprehensive investigation, combining expertise in molecular biology, immunology, and virology to unravel the intricate interactions between ADAR1 and viral replication mechanisms. Overall, the study from the University of Wisconsin-Madison highlights ADAR1 as a vital proviral factor that modulates the host's innate immune sensors to facilitate viral replication. By preventing the overactivation of PKR, ADAR1 allows HSV-1 to replicate more effectively, shedding light on potential targets for antiviral therapies. This research not only advances our understanding of viral-host interactions but also underscores the importance of RNA editing in regulating immune responses.

MedicineGeneticsBiochem

References

Main Study

1) ADAR1 p150 prevents HSV-1 from triggering PKR/eIF2α-mediated translational arrest and is required for efficient viral replication

Published 8th April, 2025

https://doi.org/10.1371/journal.ppat.1012452

Related Studies

2) Dynamic landscape and regulation of RNA editing in mammals.

https://doi.org/10.1038/nature24041


Related Articles

An unhandled error has occurred. Reload 🗙